FRANCISCO JESÚS
FERNÁNDEZ-AVILÉS DÍAZ
Catedrático de universidad
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (25)
2023
-
Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7
-
Prognostic Implications of High-Degree Atrio-Ventricular Block in Patients with Acute Myocardial Infarction in the Contemporary Era
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain
International Journal of Infectious Diseases, Vol. 136, pp. 37-42
2022
-
Atrial myxoma surgery and P-wave remodeling
PACE - Pacing and Clinical Electrophysiology, Vol. 45, Núm. 9, pp. 1160-1164
-
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia
Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453
2021
-
Apical ventricular hypertrophy in the transplanted heart: a 20-year single-center experience
Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 191-194
-
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Journal of Infection, Vol. 83, Núm. 3, pp. 306-313
-
Ischemic etiology and prognosis in men and women with acute heart failure
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
-
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction
Internal Medicine Journal, Vol. 51, Núm. 6, pp. 930-938
-
Serum biomarkers of acute rejection: Towards precision medicine in heart transplant
Journal of Heart and Lung Transplantation, Vol. 40, Núm. 10, pp. 1090-1097
-
Ticagrelor and Infection Risk in Patients with Coronary Artery Disease
Cardiology (Switzerland), Vol. 146, Núm. 6, pp. 698-704
2020
-
Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial
Open Heart, Vol. 7, Núm. 2
-
Circadian Rhythm of Deaths in a Cardiology Department: A Five-Year Analysis
Cardiology (Switzerland), Vol. 145, Núm. 6, pp. 344-349
2019
-
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction
Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
2018
-
A panel of multibiomarkers of inflammation, fibrosis, and catabolism is normal in healthy centenarians but has high values in young patients with myocardial infarction
Maturitas, Vol. 116, pp. 54-58
-
Prevalence and incidence of hyperkalaemia in the Spanish population with heart failure with reduced ejection fraction: a systematic review and populational relevance
Revista Clinica Espanola
-
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial
European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264
2017
-
La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca
Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 338-346